Seoul, South Korea

HoSung Min

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 7.7

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Unjung-Dong, KR (2014)
  • Seocho-gu, Seoul, KR (2017)
  • Seoul, KR (2017 - 2019)

Company Filing History:


Years Active: 2014-2019

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: HoSung Min: Innovator in Antigen Binding Proteins

Introduction

HoSung Min is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antigen binding proteins. With a total of 4 patents to his name, Min continues to push the boundaries of innovation in his area of expertise.

Latest Patents

Among his latest patents, Min has disclosed an isolated antigen binding protein, which includes antibodies or antibody fragments. These patents also cover pharmaceutical compositions and medicaments that comprise the antigen binding protein, isolated nucleic acid encoding it, vectors, host cells, and hybridomas useful in methods of making it. In some embodiments, the antigen binding protein comprises one to twenty-four pharmacologically active chemical moieties conjugated thereto, such as a pharmacologically active polypeptide.

Career Highlights

HoSung Min is currently associated with Amgen Inc., a leading biotechnology company. His work focuses on advancing therapeutic solutions through innovative protein engineering. His contributions have been instrumental in developing new treatments that leverage the power of antigen binding proteins.

Collaborations

Min has collaborated with notable professionals in his field, including Kenneth William Walker and Yue-Sheng Li. These collaborations have further enriched his research and development efforts, leading to groundbreaking advancements in biotechnology.

Conclusion

HoSung Min is a key figure in the field of antigen binding proteins, with a strong portfolio of patents and collaborations. His work at Amgen Inc. exemplifies his commitment to innovation and the advancement of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…